31 Fabry disease in east asia

Q2 Medicine Heart Asia Pub Date : 2019-04-01 DOI:10.1136/heartasia-2019-apahff.31
Alex P. W. Lee, Kevin Kh Kam, E. Fung, Josie T Y Chow, Yiting Fan, P. Teekakirikul, K. Wong, J. Y. Chan, David K. H. Chan, B. Sheng
{"title":"31 Fabry disease in east asia","authors":"Alex P. W. Lee, Kevin Kh Kam, E. Fung, Josie T Y Chow, Yiting Fan, P. Teekakirikul, K. Wong, J. Y. Chan, David K. H. Chan, B. Sheng","doi":"10.1136/heartasia-2019-apahff.31","DOIUrl":null,"url":null,"abstract":"Fabry disease (FD) is an X-linked inherited lysosomal storage disorder that results from mutations in the α-galactosidase A gene (GLA), leading to deficient alpha-galactosidase A (α-GalA) activity and subsequent accumulation of globotriaosylceramide (Gb3) in a variety of tissues.1 The estimated prevalence of classic FD in males ranges from 1:8000 to 1:117,000,2 likely an underestimation given its non-specific manifestations. The mutation IVS4 +919G>A (c.936+919G>A) associated with founder effect in East Asia was first described in Taiwan.3Left ventricular hypertrophy (LVH) is a hallmark of the later-onset cardiac variant of FD. The prevalence of FD among adult patients with LVH is unknown. In an ongoing FD screening programme from August 2017 through 2018, we measured plasma α-GalA activity using dried blood spot testing in 143 consecutive male patients with LVH (defined as maximal LV wall thickness ≥13 mm on echocardiography). Patients with low α-GalA activity underwent GLA gene sequencing analysis and endomyocardial biopsy. Four of 143 patients with LVH (2.8%) had low plasma α-GalA activity (0.4±0.2 μmol/L wb/hr; 3%–15% of the mean in normal controls). All 4 unrelated patients (aged 53–74 years) shared the same IVS4 +919G>A mutation with maximal LV wall thickness ranging from 14–29 mm. None had extracardiac manifestations but presented with hypertrophic cardiomyopathy, hypertension, heart failure, or aortic stenosis. Endomyocardial biopsy performed in one patient showed hypertrophic cardiomyocytes with sarcoplasmic vacuolisation. Our results suggest that FD should be considered as a cause of LVH in adult men even when other more usual causes of LVH are present. References Germain DP. Fabry disease. Orphanet J Rare Dis 2010;5:30. Meikle PJ, Hopwood JJ, Clague AE, Carey WF. Prevalence of lysosomal storage disorders. JAMA 1999;281:249. Lin HY, Chong KW, Hsu JH, Yu HC, Shih CC, Huang CH, Lin SJ, Chen CH, Chiang CC, Ho HJ, Lee PC, Kao CH, Cheng KH, Hsueh C, Niu DM. High incidence of the cardiac variant of Fabry disease revealed by newborn screening in the Taiwan Chinese population. Circ Cardiovasc Genet 2009;2:450.","PeriodicalId":12858,"journal":{"name":"Heart Asia","volume":"11 1","pages":"A13 - A13"},"PeriodicalIF":0.0000,"publicationDate":"2019-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1136/heartasia-2019-apahff.31","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Heart Asia","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/heartasia-2019-apahff.31","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Fabry disease (FD) is an X-linked inherited lysosomal storage disorder that results from mutations in the α-galactosidase A gene (GLA), leading to deficient alpha-galactosidase A (α-GalA) activity and subsequent accumulation of globotriaosylceramide (Gb3) in a variety of tissues.1 The estimated prevalence of classic FD in males ranges from 1:8000 to 1:117,000,2 likely an underestimation given its non-specific manifestations. The mutation IVS4 +919G>A (c.936+919G>A) associated with founder effect in East Asia was first described in Taiwan.3Left ventricular hypertrophy (LVH) is a hallmark of the later-onset cardiac variant of FD. The prevalence of FD among adult patients with LVH is unknown. In an ongoing FD screening programme from August 2017 through 2018, we measured plasma α-GalA activity using dried blood spot testing in 143 consecutive male patients with LVH (defined as maximal LV wall thickness ≥13 mm on echocardiography). Patients with low α-GalA activity underwent GLA gene sequencing analysis and endomyocardial biopsy. Four of 143 patients with LVH (2.8%) had low plasma α-GalA activity (0.4±0.2 μmol/L wb/hr; 3%–15% of the mean in normal controls). All 4 unrelated patients (aged 53–74 years) shared the same IVS4 +919G>A mutation with maximal LV wall thickness ranging from 14–29 mm. None had extracardiac manifestations but presented with hypertrophic cardiomyopathy, hypertension, heart failure, or aortic stenosis. Endomyocardial biopsy performed in one patient showed hypertrophic cardiomyocytes with sarcoplasmic vacuolisation. Our results suggest that FD should be considered as a cause of LVH in adult men even when other more usual causes of LVH are present. References Germain DP. Fabry disease. Orphanet J Rare Dis 2010;5:30. Meikle PJ, Hopwood JJ, Clague AE, Carey WF. Prevalence of lysosomal storage disorders. JAMA 1999;281:249. Lin HY, Chong KW, Hsu JH, Yu HC, Shih CC, Huang CH, Lin SJ, Chen CH, Chiang CC, Ho HJ, Lee PC, Kao CH, Cheng KH, Hsueh C, Niu DM. High incidence of the cardiac variant of Fabry disease revealed by newborn screening in the Taiwan Chinese population. Circ Cardiovasc Genet 2009;2:450.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
31 东亚法布里病
Fabry病(FD)是一种由α-半乳糖苷酶A基因(GLA)突变引起的X连锁遗传性溶酶体储存障碍,导致α-半乳糖苷酶A(α-GalA)活性不足,随后球三糖基神经酰胺(Gb3)在各种组织中积累。1男性典型FD的估计患病率在1:8000至1:117000之间,2鉴于其非特异性表现,可能被低估了。与东亚创始人效应相关的变异IVS4+919G>A(c.936+919G>A)首次在台湾被描述。3左心室肥大(LVH)是FD晚发心脏变异的标志。FD在LVH成年患者中的患病率尚不清楚。在2017年8月至2018年正在进行的FD筛查计划中,我们使用干血点测试对143名连续患有LVH(定义为最大左心室壁厚≥13 超声心动图上的mm)。α-GaA活性低的患者接受了GLA基因测序分析和心肌内活检。143例LVH患者中有4例(2.8%)血浆α-GalA活性较低(0.4±0.2μmol/L wb/hr;为正常对照组平均值的3%-15%)。所有4名无关患者(年龄53–74岁)共享相同的IVS4+919G>A 左心室最大壁厚为14-29的突变 无心外表现,但表现为肥厚性心肌病、高血压、心力衰竭或主动脉狭窄。一名患者的心肌内活检显示心肌细胞肥大,肌浆空泡化。我们的研究结果表明,即使存在其他更常见的LVH原因,FD也应被视为成年男性LVH的原因。参考Germain DP。法布里病。孤儿J罕见病2010;5:30。Meikle PJ,Hopwood JJ,Clague AE,Carey WF。溶酶体储存障碍的患病率。JAMA 1999;林,Chong KW,Hsu JH,Yu HC,Shih CC,Huang CH,Lin SJ,Chen CH,Chiang CC,Ho HJ,Lee PC,Kao CH,Cheng KH,Hsueh C,Niu DM。台湾华人新生儿筛查显示Fabry病心脏变异的高发病率。Circ Cardiovasc Genet 2009;2:450。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Heart Asia
Heart Asia Medicine-Cardiology and Cardiovascular Medicine
CiteScore
2.90
自引率
0.00%
发文量
0
期刊最新文献
Antiplatelet agents for preventing pre-eclampsia and its complications. Statin adherence and persistence on secondary prevention of cardiovascular disease in Taiwan. Anaesthesia use in catheter ablation for atrial fibrillation: a systematic review and meta-analysis of observational studies Association of school hours with outcomes of out-of-hospital cardiac arrest in schoolchildren Clinical consequences of poor adherence to lipid-lowering therapy in patients with cardiovascular disease: can we do better?
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1